Log In
Print
BCIQ
Print
Print this Print this
 

H3 receptor antagonist

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationCognitive dysfunction
Indication DetailsTreat cognitive disorder
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today